Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-06

Clinical Trial Update: Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of an oral growth hormone drug for fibromyalgia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral growth hormone drug

Snippet

Sponsor: Bennett, Robert, M.D. | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED